These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 15673745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y, Akşit F, Kiraz N, Kiremitçi A.
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [Abstract] [Full Text] [Related]

  • 4. Alternatives to amphotericin B for Candida rugosa infection.
    Hernandez S, Gonzalez GM, McCarthy DI, Colombo AL, Najvar LK, Bocanegera R, Graybill JR.
    J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
    [Abstract] [Full Text] [Related]

  • 5. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA, Sharp A, Morrissey G, Denning DW.
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
    An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R, Jiang Y.
    Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A, Kaw P, Banerjee P, Liu W, Chen G, Miller MH.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
    Louie A, Banerjee P, Drusano GL, Shayegani M, Miller MH.
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans.
    Han Y.
    Phytomedicine; 2007 Nov; 14(11):733-8. PubMed ID: 17913484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.